Innovage Holding Corp. (INNV)
NASDAQ:INNV
Want to see INNV full AI Analyst Report?
Earnings Data
Report Date
Sep 15, 2026After Close (Confirmed)
Period Ending
2026 (Q4)Consensus EPS Forecast
0.07Last Year’s EPS
-0.01Same Quarter Last Year
Moderate Sell
Based on 3 Analysts Ratings
Earnings Call Summary
Earnings Call Sentiment|Positive
The call conveyed meaningful operational and financial momentum: strong revenue growth, material margin expansion, improved adjusted EBITDA, positive operating cash flow, raised FY2026 guidance and active reinvestment in clinical/technology capabilities. Key risks include a wider GAAP net loss driven by litigation-related corporate G&A increases, wage and care cost inflation, ongoing de novo costs, and early signs of Medicaid rate pressure for FY2027 (with modest Medicare rate growth). On balance, the company emphasized durable improvements, disciplined execution and readiness to manage near-term rate headwinds.Company Guidance
Strong Revenue Growth
Total revenue of $251.9M in Q3 FY2026, up 15.5% YoY from $218.1M and up 5.1% QoQ, driven by higher capitation rates and member month growth.
Raised Full-Year Guidance
Updated FY2026 guidance: revenue raised to $950M–$975M and adjusted EBITDA raised to $85M–$90M, reflecting year-to-date outperformance.
Material Improvement in Adjusted EBITDA and Margin
Adjusted EBITDA of $30.5M in the quarter versus $10.8M in Q3 FY2025; adjusted EBITDA margin improved to 12.1% from 4.9% YoY and from 9.2% QoQ.
Center-Level Contribution Margin Expansion
Center-level contribution margin of $61M (24.2% of revenue) vs $40.7M (18.7% of revenue) in Q3 FY2025, a ~550 basis‑point improvement YoY and a 15.5% dollar increase QoQ from $52.8M.
Census and Member Month Growth
Served ~8,050 participants across 20 centers as of March 31, 2026 (census +6.9% YoY, +0.5% sequential). Member months of 24,060 (+6.7% YoY, +0.4% QoQ).
Positive Operating Cash Flow and Strong Liquidity
Generated $18.1M of operating cash flow in the quarter; ended the quarter with $95.5M cash and $43.1M short-term investments (total ~$138.6M) and modest total debt of $69.4M.
Clinical and Operational Efficiency Gains
Lower cost per participant driven by reduced permanent nursing facility utilization and lower pharmacy expense following transition to in‑house pharmacy services; external provider costs rose only 5% YoY despite member growth.
Strategic Investments and Growth Initiatives
Company is reinvesting in clinical teams, technology (including AI pilots for care coordination, scheduling and transportation), sales & marketing expansion and targeted growth (new centers in Florida, M&A and partnership opportunities).
INNV Earnings History
The table shows recent earnings report dates and whether the forecast was beat or missed. See the change in forecast and EPS from the previous year.
Beat
Missed
INNV Earnings-Related Price Changes
Report Date | Price 1 Day Before | Price 1 Day After | Percentage Change |
|---|---|---|---|
May 05, 2026 | $7.96 | $8.12 | +2.01% |
Feb 03, 2026 | $5.66 | $7.78 | +37.46% |
Nov 04, 2025 | $4.84 | $3.99 | -17.56% |
Sep 09, 2025 | $4.27 | $4.15 | -2.81% |
Earnings announcements can affect a stock’s price. This table shows the stock's price the day before and the day after recent earnings reports, including the percentage change.
FAQ
When does Innovage Holding Corp. (INNV) report earnings?
Innovage Holding Corp. (INNV) is schdueled to report earning on Sep 15, 2026, After Close (Confirmed).
What is Innovage Holding Corp. (INNV) earnings time?
Innovage Holding Corp. (INNV) earnings time is at Sep 15, 2026, After Close (Confirmed).
Where can I see when companies are reporting earnings?
You can see which companies are reporting today on our designated earnings calendar.
What companies are reporting earnings today?
You can see a list of the companies which are reporting today on TipRanks earnings calendar.
What is INNV EPS forecast?
INNV EPS forecast for the fiscal quarter 2026 (Q4) is 0.07.